Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid.

van Lelyveld, S F L; Nijhuis, M; Baatz, F; Wilting, I; van den Bergh, W M; Kurowski, M; de Jong, D; Hoepelman, A I M et al. · Clin Infect Dis · 2010

case_report · Level V

Where this comes from

Abstract

We report the selection of enfuvirtide-resistant human immunodeficiency virus type 1 in cerebrospinal fluid, resulting in subsequent loss of viral suppression in the plasma. This case report emphasizes the potential danger of low-level penetration of entry inhibitors into the central nervous system.

Medical subject headings